文献速递糖尿病

针对翻译后修饰胰岛素的自抗体作为预测儿童1型糖尿病的新型生物标志物

Antibodies to post-translationally modified insulin as a novel biomarker for prediction of type 1 diabetes in children.
PubMed 文献 · Diabetologia · 2017-05-20

基于ABIS队列纵向血清样本,研究中位随访10.8年间23例进展为1型糖尿病儿童与63例未进展儿童。结果发现针对氧化翻译后修饰胰岛素的自抗体(oxPTM-INS-Ab)在91.3%的进展儿童中阳性,且•OH-INS-Ab在进展儿童中较自身抗体阳性未进展儿童更常见(82.6% vs 19%,p<0.001),鉴别灵敏度74%、特异度91%。结论认为oxPTM-INS-Ab出现在临床发病前,可识别进展为1型糖尿病的儿童。

要点

  • 91.3%的进展为1型糖尿病儿童存在至少一种oxPTM-INS-Ab。
  • •OH-INS-Ab在进展儿童中占82.6%,高于自身抗体阳性未进展儿童的19%(p<0.001)。
  • •OH-INS-Ab鉴别进展与未进展儿童的灵敏度74%、特异度91%。

核心结论

  • oxPTM-INS-Ab在1型糖尿病临床发病前即存在,可识别进展为1型糖尿病的儿童。

研究设计与样本

  • 基于东南瑞典所有婴儿(ABIS)队列的纵向血清样本研究,纳入23例进展为1型糖尿病儿童和63例未进展儿童,中位随访10.8年(四分位距7.7-12.8年)。
  • 未进展组中32例为一种或多种胰岛自身抗体阳性(NP-AAB+)。

主要发现

  • 91.3%的进展为1型糖尿病儿童存在至少一种oxPTM-INS-Ab。
  • oxPTM-INS-Ab与GADA、IA-2A、IAA或ZnT8A共存的进展儿童比例分别为65.2%、56.5%、38.9%和33.3%。
  • 在GADA、IA-2A、IAA和ZnT8A阴性的进展儿童中,oxPTM-INS-Ab阳性比例分别为17.4%、26.1%、38.9%和41.6%。
  • •OH-INS-Ab在进展儿童中较NP-AAB+儿童更常见(82.6% vs 19%,p<0.001)。
  • •OH-INS-Ab鉴别进展儿童与NP-AAB+儿童的灵敏度为74%、特异度为91%。

关键数值与推荐

  • •OH-INS-Ab鉴别进展为1型糖尿病儿童与NP-AAB+儿童的灵敏度74%、特异度91%。
  • •OH-INS-Ab在进展儿童中阳性率82.6%,在NP-AAB+儿童中阳性率19%(p<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: We have shown that autoimmunity to insulin in type 1 diabetes may result from neoepitopes induced by oxidative post-translational modifications (oxPTM). Antibodies specific to oxPTM-insulin (oxPTM-INS-Ab) are present in most newly diagnosed individuals with type 1 diabetes and are more common than autoantibodies to native insulin. In this study, we investigated whether oxPTM-INS-Ab are present before clinical onset of type 1 diabetes, and evaluated the ability of oxPTM-INS-Ab to identify children progressing to type 1 diabetes. METHODS: We used serum samples collected longitudinally from the 'All Babies in Southeast Sweden (ABIS)' cohort tested for the gold standard islet autoantibodies to insulin (IAA), GAD (GADA), tyrosine phosphatase 2 (IA-2A) and zinc transporter 8 (ZnT8A). We studied 23 children who progressed to type 1 diabetes (progr-T1D) and 63 children who did not progress to type 1 diabetes (NP) after a median follow-up of 10.8 years (interquartile range 7.7-12.8). Of the latter group, 32 were positive for one or more islet autoantibodies (NP-AAB+). oxPTM-INS-Ab to insulin modified by •OH or HOCl were measured by our developed ELISA platform. RESULTS: Antibodies to at least one oxPTM-INS were present in 91.3% of progr-T1D children. oxPTM-INS-Ab co-existed with GADA, IA-2A, IAA or ZnT8A in 65.2%, 56.5%, 38.9% and 33.3% progr-T1D children, respectively. In addition, oxPTM-INS-Ab were present in 17.4%, 26.1%, 38.9% and 41.6% of progr-T1D children who were negative for GADA, IA-2A, IAA and ZnT8A, respectively. •OH-INS-Ab were more common in progr-T1D children than in NP-AAB+ children (82.6% vs 19%; p < 0.001) and allowed discrimination between progr-T1D and NP-AAB+ children with 74% sensitivity and 91% specificity. None of the NP-AAB- children were positive for oxPTM-INS-Ab. CONCLUSIONS/INTERPRETATION: oxPTM-INS-Ab are present before the clinical onset of type 1 diabetes and can identify children progressing to type 1 diabetes.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Strollo R, Vinci C, Napoli N, et al. Antibodies to post-translationally modified insulin as a novel biomarker for prediction of type 1 diabetes in children. Diabetologia. 2017. PMID: 28526919. doi:10.1007/s00125-017-4296-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。